Study Shows Utility of Blood Test for Prostate Cancer Risk Assessment
CLEVELAND, OH — Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, recently announced the publication of a large real-world clinical utility study in Urology Practice, a...
Biopharma M&A Expected to Rebound After Sluggish 2021
...
Already a member? Log in here
Quest and Walmart Team Up to Provide Easier Access to Lab Tests
...
Already a member? Log in here
